NCT00255749View on ClinicalTrials.gov

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

April 30, 2007

Conditions
AnemiaLeukemiaLymphomaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmPrecancerous ConditionUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

epoetin alfa

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00255749 - Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer | Biotech Hunter | Biotech Hunter